SUMOylation Regulates TDP-43 Splicing Activity and Nucleocytoplasmic Distribution

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• TDP-43 protein aggregates in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
• Mechanisms like impaired transport and post-translational modifications (PTMs) contribute to TDP-43 aggregation.
• SUMOylation is a PTM affecting various cellular processes.

Purpose of the Study:

• To investigate the regulatory role of SUMOylation on TDP-43 function and localization.
• To explore SUMOylation as a potential therapeutic target for ALS and FTD.

Main Methods:

• Assessed TDP-43 SUMOylation in the nuclear compartment.
• Utilized a SUMO-mutant TDP-43 (K136R) to study its effects on splicing and localization.
• Investigated deSUMOylation using SENP1 enzyme and TS-1 peptide.

Main Results:

• TDP-43 undergoes SUMOylation at lysine 136 and a SUMO-interacting motif.
• SUMOylation impacts TDP-43 splicing activity and its recruitment to stress granules.
• DeSUMOylation increased cytoplasmic TDP-43 localization and promoted aggregate formation of a TDP-43 fragment.

Conclusions:

• SUMOylation is a key regulator of TDP-43 splicing and cellular trafficking.
• Targeting TDP-43 SUMOylation offers a novel therapeutic strategy for ALS and FTD.
• Dysregulation of TDP-43 SUMOylation may contribute to pathological aggregation.